These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
243 related items for PubMed ID: 30717601
21. A prospective study of the responsiveness of depression and suicidal ideation in acne patients to different phases of isotretinoin therapy. Kellett SC, Gawkrodger DJ. Eur J Dermatol; 2005; 15(6):484-8. PubMed ID: 16280305 [Abstract] [Full Text] [Related]
22. Isotretinoin has no negative effect on attention, executive function and mood. Ergun T, Seckin D, Ozaydin N, Bakar Ö, Comert A, Atsu N, Demircay Z, Yoney H, Zaimoglu S. J Eur Acad Dermatol Venereol; 2012 Apr; 26(4):431-9. PubMed ID: 21545542 [Abstract] [Full Text] [Related]
23. Psychiatric reactions to isotretinoin in patients with bipolar disorder. Schaffer LC, Schaffer CB, Hunter S, Miller A. J Affect Disord; 2010 May; 122(3):306-8. PubMed ID: 19783054 [Abstract] [Full Text] [Related]
24. Suicide, depression, and isotretinoin: is there a causal link? Jacobs DG, Deutsch NL, Brewer M. J Am Acad Dermatol; 2001 Nov; 45(5):S168-75. PubMed ID: 11606949 [Abstract] [Full Text] [Related]
25. Changes of psychiatric parameters and their relationships by oral isotretinoin in acne patients. Hahm BJ, Min SU, Yoon MY, Shin YW, Kim JS, Jung JY, Suh DH. J Dermatol; 2009 May; 36(5):255-61. PubMed ID: 19382995 [Abstract] [Full Text] [Related]
26. Effects of isotretinoin treatment on sleep in patients with severe acne: a pilot study. Ismailogullari S, Ferahbas A, Aksu M, Baydemir R, Utas S. J Eur Acad Dermatol Venereol; 2012 Jun; 26(6):778-81. PubMed ID: 21545544 [Abstract] [Full Text] [Related]
27. A pilot study evaluating anxiety and depressive scores in acne patients treated with isotretinoin. Ferahbas A, Turan MT, Esel E, Utas S, Kutlugun C, Kilic CG. J Dermatolog Treat; 2004 Jun; 15(3):153-7. PubMed ID: 15204147 [Abstract] [Full Text] [Related]
28. Depression screening using health questionnaires in patients receiving oral isotretinoin for acne vulgaris. Schrom K, Nagy T, Mostow E. J Am Acad Dermatol; 2016 Jul; 75(1):237-9. PubMed ID: 27317530 [Abstract] [Full Text] [Related]
29. Use of isotretinoin and risk of depression in patients with acne: a systematic review and meta-analysis. Li C, Chen J, Wang W, Ai M, Zhang Q, Kuang L. BMJ Open; 2019 Jan 21; 9(1):e021549. PubMed ID: 30670500 [Abstract] [Full Text] [Related]
31. Minimize the regular laboratory monitoring during the systemic isotretinoin treatment: data of 704 patients with acne vulgaris. Öktem A, Hayran Y, Arı E, Yalçın B. J Dermatolog Treat; 2019 Dec 21; 30(8):813-817. PubMed ID: 30836808 [Abstract] [Full Text] [Related]
37. Myths of isotretinoin therapy in patients with acne: a personal opinion. Alcalay J. J Drugs Dermatol; 2004 Jul 21; 3(2):179-82. PubMed ID: 15098974 [Abstract] [Full Text] [Related]
38. The oral adverse effects of isotretinoin treatment in acne vulgaris patients: A prospective, case-control study. Erdemir U, Okan G, Gungor S, Tekin B, Yildiz SO, Yildiz E. Niger J Clin Pract; 2017 Jul 21; 20(7):860-866. PubMed ID: 28791981 [Abstract] [Full Text] [Related]
40. Comparison of depression, anxiety and life quality in acne vulgaris patients who were treated with either isotretinoin or topical agents. Kaymak Y, Taner E, Taner Y. Int J Dermatol; 2009 Jan 21; 48(1):41-6. PubMed ID: 19126049 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]